Sunday, May 28, 2023

Continuous Glucose Monitoring (CGM) Devices—a deep-dive on How Athletics Trend Redefines Digital Health

Athletes have exhibited immense traction in tracking glucose levels continuously. So much so that CGM technology has become sought-after to see how their training and food influence their blood glucose levels all the time. The advanced CGM devices enable consumers to make diet and training decisions to help boost their performance. There have been instances in the past of the National Football League (NFL) using CGM devices. Some well-established brands, such as Abbott (Libre Sense), Supersapiens and Nutrisense, have furthered their penetration to tap into the global market. 

Sports and fitness enthusiasts have joined the bandwagon to enhance their fitness performance. It is worth mentioning that CGM is less invasive and some devices can be connected to Bluetooth, making the product highly popular among amateur and professional athletes. Grand View Research is gearing up to add OTC CGM devices used in non-diabetes applications and their impact on the blood glucose monitoring device market in its repository. The final report, coupled with the database, will emphasize the following dynamics:

Opportunities for CGM manufacturers and analytics service providers

Trends that can influence the prospect and application of CGM devices in fitness enthusiasts and diabetic patients.

Insights on Medicare and Medicaid coverage.

CGMs pricing among athletes and patients.

Get your copy or request a free sample of the report “A Study On New Vertical Growth Opportunities for Continuous Glucose Monitoring Devices,” compiled and published by Grand View Research. 

Vertical Growth Opportunities for CGM Devices Report Scope

Attribute

Details

Patient Demographics

  • Total Population
  • People with diabetes
  • People with undiagnosed diabetes
  • Deaths attributable to diabetes
  • Sport enthusiasts
  • Number of athletes

Pricing

Pricing for CGMs in diabetic patients vs Athletes

Reimbursement Differences

Coverage for Medicare and Medicaid

Regions

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait


About Us
Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.

Thursday, May 25, 2023

Diabetes Type 1 and Type 2—a Study on Country-wise Disease Demographics

The pervasiveness of diabetes type 1 and type 2 has had a notable impact on people's well-being and hampered the healthcare system's sustainability. A study forecasts that around 783.7 million people will live with diabetes by 2045. Strain diabetes puts on the economy and the complications linked to the disease have warranted a holistic approach to develop strategies to minimize prevalence and foster healthcare. There is a general acceptance that physical activity and healthy food habits could reduce obesity rates and diabetes risks. 

Researchers, manufacturers and other stakeholders are navigating growth and opportunities in diabetes devices and treatment. The development of advanced treatment options could be pronounced amid the aging population. A healthy lifestyle and better diabetes medications are expected to make a difference in minimizing diabetes. The final report, coupled with the database, will deep-dive into the following dynamics:

Decision-making process and customer buying pattern.

Reimbursement landscape and diabetes-related expenditure per person.

Treatment options and related costs across countries.

Comparative prevalence of diabetes.

Get your copy or request a free sample of the report “Disease Demographics for Diabetes Type 1 and Type 2, 2023,” compiled and published by Grand View Research. 

Disease Demographics for Diabetes Type 1 and Type 2 Report Scope

Attribute

Details

Patient Demographics

  • Total Population
  • People with diabetes
  • People with undiagnosed diabetes
  • Deaths attributable to diabetes

Treatment Options

  • Type 1 Diabetes
    • Insulin
    • Diet
    • Blood glucose monitoring
  • Type 2 Diabetes
    • Oral Medications
    • Diet
    • Exercise
    • Blood glucose monitoring
    • Insulin

Treatment Cost Per Patient

  • Total diabetes-related health expenditure, USD Million
  • Diabetes-related health expenditure per person, USD

Quality of Life

  • Disability-adjusted life years (DALYs)

Comorbidity Analysis

  • Diabetic foot ulcer
  • Cardiovascular disease (CVD)
  • Diabetic retinopathy
  • Diabetic neuropathy
  • Diabetic nephropathy

Reimbursement Differences

  • Coverage for Medicare and Medicaid
    • Type 1 Diabetes
    • Type 2 Diabetes

Regions

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Related Reports:

About Us
Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.

Wednesday, May 24, 2023

Viral Vector—Perusal on Adeno-associated Viruses (AAVs) in Gene Therapy Development

The medical industry expects viral vectors to grow in prominence in transferring genetic material into the genetic composition of cells. Adeno-associated Viruses (AAVs) have become sought-after in gene therapy as they can deliver genetic material to cells and do not cause disease. Predominantly, adenovirus, retrovirus, herpes simplex virus and lentivirus, among others, are used to transfer genetic material into cells’ genetic composition. Technological advancements in manufacturing AAV vectors have encouraged stakeholders to boost their portfolios. An uptick in research activities in viral vector-based cell and gene therapies has redefined the global landscape. For instance, in 2020, over 100 gene-therapy products were observed in clinical trials.

Pharma companies, investors, venture capitalists and other stakeholders will possibly explore the growth potential in viral vectors. The final report, along with the database, will deep-dive into the following industry dynamics:

AAV vectors approved by governing bodies, including FDA and the European Medicines Agency. Zolgensma was approved by EMA and FDA in 2020 and 2019, respectively, while Luxturna received the green signal from FDA in 2017 and EMA in 2018. 

Insights on potential challenges for AAV manufacturers, such as cost, degradation during supply chain and preparation of stable viral vectors.

Influence of the COVID-19 pandemic on vaccine development.

Acquisitions of biotech startups

Get your copy or request a free sample of the report “Viral Vector Development - Focus on Adeno-associated Virus, 2018 – 2021,” compiled and published by Grand View Research.

Viral Vector Report Scope

Attribute

Details

Market Lineage

  • % Captured by AAV within Viral Vectors
  • Understanding of the parent market and ancillary industries
    • Plasmid DNA Contract Manufacturing
    • Cell & Gene Therapy Clinical Trials Market

Industry Dynamics

  • Viral Vector based gene therapy development
  • AAV Development workflow
  • Pipeline for AAV
  • Capitalist funding in the industry
  • Development Process

Deep dive Analysis

  • Understanding of AAV v/s Lentiviral v/s other viral vectors
  • Cost of manufacturing (based on batch size) - a case study
  • Case study on setting up a development plant

Competition Analysis in CDMOs

  • Companies with products in clinical trials
  • Various bioreactors used for development
  • Strategic initiatives undertaken in the last 5 years

Observation and Recommendations

This section will summarize the entire study and provide analyst insights with regards to key methods of development, technological advancements, and competitive profiling


About Us
Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.

Tuesday, May 23, 2023

Green Packaging Industry Invests in ESG Pillars to Bolster Company’s Strategy

Fast-moving consumer goods (FMCG) companies, packaging manufacturers and retailers have taken a giant stride towards a circular economy with investments in green packaging. Consumers’ preferences for sustainable packaging and the repercussions of plastics on the environment have prompted governing bodies to look beyond plastic bans.

Spain introduced Plastic Tax (a special tax on non-reusable plastic packaging) by Law 7/2022 to promote a circular economy and manage waste and contaminated soil; the law came into force on January 1, 2023. In August 2021, the Whitehouse introduced REDUCE (Rewarding Efforts to Decrease Unrecycled Contaminants in Ecosystems) Act to encourage recycling and impose a USD 0.10 per pound fee on virgin plastic resins used for the single-use product, rising up to USD 0.20 per pound in 2024.

With single-use plastic becoming ubiquitous, the burden on the environment and society has become a grave concern. So much so that green packaging has become synonymous with biodegradability and instrumental in fostering corporate social responsibility. That said, several companies have received the flak for greenshifting—a part of greenwashing wherein brands shift blame from themselves to consumers in a way that would not hold specific companies accountable for the environmental crisis. Several pundits, including Heather Rogers, claimed that Coca-Cola and companies, such as Dixie Cup launched—Keep America Beautiful—aimed at making Americans believe that it was their personal responsibility to keep the environment clean. 

Environmental claims are pervasive in Europe, too. The Guardian cited a Changing Markets Foundation report, noting that P&G ‘s Head and Shoulders shampoo bottles—dyed blue—cannot be recycled further, although these products are touted as being made of beach plastic. Meanwhile, P&G stated that the pack was recyclable and is no longer available in the U.K. While consumer protection laws are in place, better ESG performance has become invaluable for brands to avoid landfills and bolster share value. 

Amcor Invests in Responsible Packaging to Enhance Environmental Profile

Sustainable packaging solutions have received global traction to facilitate a circular economy. Recycled-ready products can be the mainstay for brands striving to keep abreast of ESG trends. For instance, Amcor is gearing up for 30% recycled material across its portfolio by 2030, up from the previous target of 10% by 2025. In January 2022, the company committed to establishing science-based targets and attaining net-zero emissions by 2050. It is contemplating augmenting recycling value for PET Thermoformed Trays; boosting value in PET recycling; using on-pack recycling instruction; minimizing virgin plastic use in B2B plastic packaging; and bolstering recycling value in rigid HDPE and PP. 

Amcor has forayed its penetration in Latin America to ramp up “inclusive and economically viable recycled projects.” It joined forces with Delterra in Olavarría, Argentina to fund the project boosting recycling, waste collection and composting. Olavarría could recover 2,000 metric tons of plastic annually by 2024. It is worth mentioning that the brand is poised to make all packaging recyclable, reusable or compostable by 2025. In FY 2022, Amcor Flexibles Latin America teamed up with a customer to create an innovative compostable packaging solution for paper-made butter and margarine. 

Is your business one of participants to the Green Packaging Industry? Contact us for focused consultation around ESG Investing, and help you build sustainable business practices

Mondi Navigates Social Initiatives to Enhance Sustainability Solutions

The need for positive social practices has prompted industry players to inject funds into diversity, health & well-being, and community welfare and play a part in overcoming sustainability challenges. Mondi expanded its footprint in Africa through investments in corporate social projects and offering sustainability training opportunities in South Africa. Besides, in 2022, it poured €8.9 million (approximately USD 9.8 million) into social initiatives to underpin environmental protection, health, education, infrastructure and local enterprise. Amidst Russia’s invasion of Ukraine, the packaging and paper group donated €2 million (roughly USD 2.2 million) to the World Food Program for humanitarian causes. 

Mondi furthered personal development opportunities, mental health and diversity and inclusion. The company tested Mental Wellbeing Index for employee surveys across different locations to emphasize safety, mental health, inclusive behavior and climate action. Additionally, in 2022, approximately 31% of all employees participated in the online Performance and Development Review Process. 

DS Smith Reinforces Good Corporate Governance

The principles of sound corporate behavior, board diversity, transparency, ethics & compliance and anti-corruption have become paramount to underscore brand position. DS Smith is aiming to engage 100% of its people on the circular economy and is optimistic about removing 1 billion pieces of problem plastics from supermarkets by 2025. Bullish corporate policies could complement buoyant strategies to achieve the target and spearhead the ESG rankings. The company has formed a circular business around sustainable packaging. 

The prevalence of bottlenecks, such as bribery and corruption, has compelled DS Smith to introduce strict anti-bribery and anti-corruption policies. The company has exhorted a zero-tolerance approach to bribery and corruption and urged to conduct third-party background checks by reviewing third-party’s likely business partners; and the payment terms, among others. The company also prepares a companion report, along with the sustainability report annually, to provide a deep-dive into the quantitative detail of ESG and sustainability performance across non-financial indicators. 

At a time when sustainable packaging could bring a green revolution, forward-looking companies are expected to inject funds into ESG strategies. For instance, in March 2023, DuPont joined forces with the members of the Water Resilience Coalition to infuse USD 3 million to boost access to safe water and sanitation. The high-impact investment validates Grand View Research’s projection of the global green packaging market at 6.1% CAGR from 2020 through 2028. 

About Astra – ESG Solutions by Grand View Research

Astra is the Environmental, Social, and Governance (ESG) arm of Grand View Research Inc. - a global market research publishing & management consulting firm.

Astra offers comprehensive ESG thematic assessment & scores across diverse impact & socially responsible investment topics, including both public and private companies along with intuitive dashboards. Our ESG solutions are powered by robust fundamental & alternative information. Astra specializes in consulting services that equip corporates and the investment community with the in-depth ESG research and actionable insight they need to support their bottom lines and their values. We have supported our clients across diverse ESG consulting projects & advisory services, including climate strategies & assessment, ESG benchmarking, stakeholder engagement programs, active ownership, developing ESG investment strategies, ESG data services, build corporate sustainability reports. Astra team includes a pool of industry experts and ESG enthusiasts who possess extensive end-end ESG research and consulting experience at a global level.

For more ESG Thematic reports, please Visit Astra ESG Solutions, powered by Grand View Research


Monday, May 22, 2023

Xenotransplantation—Study on Animal-to-Human Organ Transplantation

Patients dying on the waiting list hoping to get lifesaving organ transplants have strengthened the significance of cells and tissue transplantation. The studies on xenotransplantation have become pronounced with an emphasis on bone-related conditions, wound healing/burn care, dental, breast reconstruction and adenocarcinoma.

Frontiers of transplanting nonhuman organs or tissues into human recipients have put the spotlight on pigs. While fish skins have been successfully used for burn wounds, pigs have become sought-after in xenotransplantation studies. Some of the analyses have pegged the success rate for the pig to primate transplantation from 60% to 80%. 

The report, along with the database, highlights the following dynamics:

Potential applications of xenotransplantation.

Genetically engineered pigs.

Insights on research activities.

Mega trends and growth opportunities redefining the global landscape.

Get your copy or request for a free sample of the report “Xenotransplantation and Its Potentials - Outlook on Ongoing Studies,” compiled and published by Grand View Research.

 Xenotransplantation Report Scope

Attribute

Details

Research Studies

  • Total Studies
  • Success rates
  • Disease areas
  • Alternative applications

Conditions covered

  • Wound healing/burn care
  • Bone related conditions
  • Dental
  • Adenocarcinoma
  • Breast reconstruction

Animals covered

  • Pigs
  • Fish

Comorbidity Analysis

  • Side effects
  • Success rates 

Regions

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Related Report:

About Us
Grand View Research, Inc. is a market research and consulting comp    make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.






Healthcare Outsourcing Industry—an Exposition of Top 10 Trends Reshaping the Global Dynamics

The rising applications of CROs, including augmented reality (AR), virtual reality (VR) and mixed reality (MR) have fueled the demand for healthcare outsourcing. The adoption of ML and AI has become pronounced in the wake of increasing scrutiny to adhere to regulatory compliance of healthcare products. For instance, AI can propel transparency with accurate results and enhance the efficiency and pace of product development. Since AI is less prone to human error, it enables better quality control to bolster decision-making. 

An uptick in the number of decentralized clinical trials (DCTs) in 2021 leveraged forward-looking companies to penetrate the pharmaceutical industry. The number of DCTs was forecast to be pegged at 1300 trials by 2022-end. 

The report will offer a bird’s eye view of qualitative development/s in the healthcare outsourcing landscape. The final report, coupled with the database, will offer insights into the following dynamics:

Capacity expansion in niche markets; decoupling of service offerings; rise in safety assessment; and extended reality.

Diversifying geographical footprints and mergers & acquisitions. In 2021, over 132 M&As were completed.

The expanding footprint of personalized medication, genomics and biosimilars.

IoT implementation and innovations.

Get your copy or request for a free sample of the report “Healthcare Outsourcing Industry - Analysis of Top 10 Trends,” compiled and published by Grand View Research. 

Healthcare Outsourcing Industry Report Scope

Attribute

Details

Divestiture/Consolidation

Activities

  • List of mergers, by CROs/CMOs
  • List of acquisitions, by CROs/CMOs
  • List of divestitures, by CROs/CMOs
  • List of partnerships, by CROs/CMOs

Innovation

  • New product launches, by Industry
  • Introduction of generics (for pharmaceutical drugs only)

Globalization

  • Analysis of level of globalization
  • Regional presence of top 50 CROs & CMOs
  • Political pacts/policies impacting international business

Virtual Augmentation

  • Virtualization in R&D
  • Virtualization in Business operations implementation

Service Portfolio Modification

  • Study of the business organization restructurings
    • Owing to M&A activities
    • Owing to modernization/revolution

Capacity Expansion in Niche Markets

  • Analysis of current demand and supply
  • Focused capacity expansions from 2020 till 2023

Related Reports:


About Us
Grand View Research, Inc. is a market research and consulting comp    make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.

Sunday, May 21, 2023

ESG Factors Driving the Growth of Electric Passenger Cars Industry

Sustainability for mobility has prompted electric passenger cars industry players to prioritize environmental, social and governance (ESG) goals. Heightened demand for decarbonization and the need to bring sustainability perspectives into management have encouraged incumbent companies to foster their ESG strategies. Climate change response has become global, suggesting an emphasis on the environment throughout the value chain, including design, manufacturing, procurement, logistics and disposal. 

Premium automotive brands have shifted their attention toward sustainability to improve customer trust, boost compliance, enhance investor confidence and bolster brand reputation. A transition towards electric brands comes against the backdrop of soaring inflation, supply chain disruption and higher interest rates. In an unexpected turn of events, the exorbitant price of lithium propelled production costs for EVs; Russia’s Ukraine invasion and surging energy prices have had an overarching influence on the global economy. 

AB Volvo Redefines Scope 3 Emissions for Consumer-Driven Culture

Although 2022 was a year full of challenges for automakers, 2023 has promised to provide compelling opportunities to navigate ESG strategies. Predominantly, AB Volvo has taken a giant stride to combat climate change—contemplating minimizing scope 1 & scope 2 emissions by 50% by 2030. The Swedish multinational company aims to cut scope 3 emissions by 40% per vehicle Km from trucks and buses, respectively, and 30% from construction equipment by 2030. The automotive giant has upped its efforts to do away with conventional energy sources and adopt renewable sources. During 2022, there was a 32% reduction in tailpipe emissions per average vehicle (vis-à-vis 2018 baseline). The company is gearing up to develop renewable electricity for vehicle charging, alluding strong demand for bio-based materials. 

Is your business one of participants to the Electric Passenger Cars Industry? Contact us for focused consultation around ESG Investing, and help you build sustainable business practices

Toyota Prioritizes Social Sustainability

Workplace safety, reduction in accidents and diversity are shaping the future of transportation as automakers inject funds into state-of-the-art products and services. With the demand for personal vehicles soaring, sustainable development has become invaluable to creating a prosperous society. To illustrate, Toyota Australia has powered 7,883 solar panels to its Altona Toyota Parts Centre, which produces 2.5MW. In FY 2022, the auto giant incentivized Toyota and Lexus customers to recycle 1,954 hybrid batteries to foster battery recycling. The automotive brand donated USD 3.4 million to community partners working in sustainability, education, traffic safety, social justice and the environment. Moreover, Toyota Kirloskar Motor, a Joint Venture between Toyota and Kirloskar, trained around 43,673 supplier members to boost environment and social performance. 

Mercedes-Benz Ups Governance Stewardship

Decision-making bodies have exhibited concerted efforts toward transparency, ethics & compliance, robust corporate governance and board diversity to bolster their ESG performance. In 2021, Mercedes-Benz made a resource conservation policy to minimize the energy consumption per vehicle for cars by 43% and 25% for Vans by 2030. The Luxury vehicle company has introduced supply chain policies to allow purchasers to track material data with the help of blockchain technology. The automotive brand has propelled its diversity and equity portfolio to keep up with the Sustainable Development Goals, including gender equality and reduced inequalities. As of December 2021, Mercedes-Benz had 22.5% of women in senior management positions, while the Board of Management had 3 women and 5 men. 

The competitive scenario indicates that forward-looking companies could focus on organic and inorganic strategies to expand their global footprint. In doing so, well-established players will likely invest in technological advancements, innovations, product offerings, collaborations, R&D activities and mergers & acquisitions. The electric passenger cars market size stood at USD 120.81 billion in 2020 and will witness a healthy CAGR of 32.5% between 2021 and 2028. The outlook suggests that the sustainability and success of automakers could depend upon sound corporate governance, bullish environmental targets and social sustainability. 

About Astra – ESG Solutions by Grand View Research

Astra is the Environmental, Social, and Governance (ESG) arm of Grand View Research Inc. - a global market research publishing & management consulting firm.

Astra offers comprehensive ESG thematic assessment & scores across diverse impact & socially responsible investment topics, including both public and private companies along with intuitive dashboards. Our ESG solutions are powered by robust fundamental & alternative information. Astra specializes in consulting services that equip corporates and the investment community with the in-depth ESG research and actionable insight they need to support their bottom lines and their values. We have supported our clients across diverse ESG consulting projects & advisory services, including climate strategies & assessment, ESG benchmarking, stakeholder engagement programs, active ownership, developing ESG investment strategies, ESG data services, build corporate sustainability reports. Astra team includes a pool of industry experts and ESG enthusiasts who possess extensive end-end ESG research and consulting experience at a global level.

For more ESG Thematic reports, please visit Astra ESG Solutions, powered by Grand View Research


ESG Initiatives In The Bakery Product Industry

Embedding the value of environmental, social and governance (ESG) in the  bakery product industry  has become a vital cog in augmenting reve...